Financial insights of XENE

MyFinsight

For the quarter ending 2025-09-30.

Unit: Dollar

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Collaboration revenue (note 9)	0	0	7,500,000	-
Research and development	77,054,000	74,985,000	61,200,000	52,598,500
General and administrative	19,282,000	19,244,000	19,038,000	17,226,000
Total operating expenses	96,336,000	94,229,000	80,238,000	69,824,500
Loss from operations	-96,336,000	-94,229,000	-72,738,000	-69,824,500
Interest income	6,206,000	7,199,000	8,083,000	10,485,750
Foreign exchange gain (loss)	-89,000	1,698,000	35,000	-266,000
Total other income	6,117,000	8,897,000	8,118,000	10,219,750
Loss before income taxes	-90,219,000	-85,332,000	-64,620,000	-59,604,750
Income tax recovery (expense)	677,000	-626,000	427,000	-1,022,250
Net loss	-90,896,000	-84,706,000	-65,047,000	-58,582,500
Unrealized gain on available-for-sale securities (note 5)	364,000	949,000	776,000	-
Net loss attributable to common shareholders	-	-	-	-58,582,500
Comprehensive loss	-90,532,000	-83,757,000	-64,271,000	-

Earnings per share, basic, total	-1.15	-1.07	-0.83	-0.753
Earnings per share, diluted, total	-1.15	-1.07	-0.83	-0.753
Weighted average number of shares outstanding, basic, total	79,247,976	78,953,445	78,687,503	19,473,660.75
Weighted average number of shares outstanding, diluted, total	79,247,976	78,953,445	78,687,503	19,473,660.75